Search research articles
Contact Us
Filters
Showing results (21-30 of 102) with videos related to
Page
of 11
Sort By:
Leukemia Research
|
December 1, 1995
Clonal dominance of RadLV-induced lymphomas
O Avni, E Yefenof, M Kotler
Cellular Immunology
|
June 15, 1977
Relationships between complement activation, complement binding, and EBV absorption by human hematopoietic cell lines
E Yefenof, G Klein, K Kvarnung
Cancer Chemotherapy and Pharmacology
|
January 1, 1991
Antitumor effects of ketoconazole and trifluoperazine in murine T-cell lymphomas
S Naftalovich, E Yefenof, Y Eilam
Cellular Immunology
|
September 1, 1984
Complement-dependent cellular cytotoxicity due to alternative pathway C3 activation by the target cell membrane
E Yefenof, I Yron, E Klein
Molecular Immunology
|
December 1, 1984
Contribution of activated C3 to lymphocyte-mediated target lysis: complement-dependent cellular cytotoxicity
E Yefenof, E Klein, I Yron
Journal of the National Cancer Institute
|
May 1, 1982
Nonimmunogenic radiation-induced lymphoma: immunity induction by a somatic cell hybrid
E Yefenof, M Goldapfel, R Ber
International Journal of Cancer
|
July 30, 1991
Radiation leukemia virus (RadLV)-induced leukemogenesis is associated with an increased number and activity of thymic macrophages
E Messika, R Gallily, E Yefenof
Cancer Research
|
April 15, 1991
Quantitation, in vitro propagation, and characterization of preleukemic cells induced by radiation leukemia virus
E Yefenof, S Epszteyn, M Kotler
Cancer Immunology, Immunotherapy : CII
|
January 1, 1991
Potentiation of T cell immunity against radiation-leukemia-virus-induced lymphoma by polysaccharide K
E Yefenof, E Einat, E Klein
Immunology Letters
|
January 1, 1983
Increased humoral and cellular immunity in mice inoculated with allogeneic tumor cells attached to microcarrier beads
E Yefenof, S Schwartz, A Katz-Gross
Page
of 11
Search research articles
Search
Showing results (21-30 of 102) with videos related to
Sort By:
Page
of 11
Leukemia Research
|
December 1, 1995
Clonal dominance of RadLV-induced lymphomas
O Avni, E Yefenof, M Kotler
Cellular Immunology
|
June 15, 1977
Relationships between complement activation, complement binding, and EBV absorption by human hematopoietic cell lines
E Yefenof, G Klein, K Kvarnung
Cancer Chemotherapy and Pharmacology
|
January 1, 1991
Antitumor effects of ketoconazole and trifluoperazine in murine T-cell lymphomas
S Naftalovich, E Yefenof, Y Eilam
Cellular Immunology
|
September 1, 1984
Complement-dependent cellular cytotoxicity due to alternative pathway C3 activation by the target cell membrane
E Yefenof, I Yron, E Klein
Molecular Immunology
|
December 1, 1984
Contribution of activated C3 to lymphocyte-mediated target lysis: complement-dependent cellular cytotoxicity
E Yefenof, E Klein, I Yron
Journal of the National Cancer Institute
|
May 1, 1982
Nonimmunogenic radiation-induced lymphoma: immunity induction by a somatic cell hybrid
E Yefenof, M Goldapfel, R Ber
International Journal of Cancer
|
July 30, 1991
Radiation leukemia virus (RadLV)-induced leukemogenesis is associated with an increased number and activity of thymic macrophages
E Messika, R Gallily, E Yefenof
Cancer Research
|
April 15, 1991
Quantitation, in vitro propagation, and characterization of preleukemic cells induced by radiation leukemia virus
E Yefenof, S Epszteyn, M Kotler
Cancer Immunology, Immunotherapy : CII
|
January 1, 1991
Potentiation of T cell immunity against radiation-leukemia-virus-induced lymphoma by polysaccharide K
E Yefenof, E Einat, E Klein
Immunology Letters
|
January 1, 1983
Increased humoral and cellular immunity in mice inoculated with allogeneic tumor cells attached to microcarrier beads
E Yefenof, S Schwartz, A Katz-Gross
Page
of 11